These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3643676)

  • 21. Blood donor screening by Wellcome anti-HIV kits.
    Taylor HL; Moulsdale HJ; Mortimer PP
    Lancet; 1987 Mar; 1(8533):631-2. PubMed ID: 2881167
    [No Abstract]   [Full Text] [Related]  

  • 22. HIV antibody in blood donors in Argentina.
    Muchinik G; Picchio G; Livellara B; Martín E; Gatti H; Morisoli L; González L; Taborda M; Fay O
    Boll Ist Sieroter Milan; 1987; 66(6):491-2. PubMed ID: 3453153
    [No Abstract]   [Full Text] [Related]  

  • 23. An idiotypic network model of AIDS immunopathogenesis.
    Hoffmann GW; Kion TA; Grant MD
    Proc Natl Acad Sci U S A; 1991 Apr; 88(8):3060-4. PubMed ID: 1901653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antibodies reacting with the antigens of the human immunodeficiency virus in systemic lupus erythematosus].
    Nasonov EL; Aleksandrova LZ; Korneeva MN; Solov'ev SK; Nosik DN
    Ter Arkh; 1987; 59(7):40-2. PubMed ID: 3499678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specificities of leucocyte alloantibodies in transfusion-related acute lung injury and results of leucocyte antibody screening of blood donors.
    Reil A; Keller-Stanislawski B; Günay S; Bux J
    Vox Sang; 2008 Nov; 95(4):313-7. PubMed ID: 19138261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of antibodies against human immunodeficiency virus (HIV) and other infectious disease markers in blood donors from the city of Puebla].
    Marín López A
    Rev Invest Clin; 1987; 39(3):219-22. PubMed ID: 3481100
    [No Abstract]   [Full Text] [Related]  

  • 27. Screening blood donors for human immunodeficiency virus antibody: cost-benefit analysis.
    Eisenstaedt RS; Getzen TE
    Am J Public Health; 1988 Apr; 78(4):450-4. PubMed ID: 3126676
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-HLA class II antibodies in kidney retransplant patients.
    Arnold ML; Pei R; Spriewald B; Wassmuth R
    Tissue Antigens; 2005 Apr; 65(4):370-8. PubMed ID: 15787721
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.
    Golding H; Robey FA; Gates FT; Linder W; Beining PR; Hoffman T; Golding B
    J Exp Med; 1988 Mar; 167(3):914-23. PubMed ID: 3127528
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A method for ensuring anonymity for AIDS antibody screening away from blood banks at alternate sites.
    Greenwalt TJ; Dumaswala UJ; Werner AL; Hsueh YS; Zelenski KR
    JAMA; 1986 Oct 24-31; 256(16):2198. PubMed ID: 3463769
    [No Abstract]   [Full Text] [Related]  

  • 31. [Carriers of HBs antigen, anti-HIV antibodies and their association with blood donors in Brazzaville].
    Yala F; Olembe C; M'Pelé P; Rosenheim M
    Bull Soc Pathol Exot Filiales; 1988; 81(1):32-9. PubMed ID: 3165308
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pooling of sera for human immunodeficiency virus (HIV) testing: an economical method for use in developing countries.
    Emmanuel JC; Bassett MT; Smith HJ; Jacobs JA
    J Clin Pathol; 1988 May; 41(5):582-5. PubMed ID: 3164325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I infected individuals.
    Dis Markers; 1990; 8(3):165-6. PubMed ID: 1703062
    [No Abstract]   [Full Text] [Related]  

  • 34. The impact of repeated DR mismatching and preformed antibodies on human kidney retransplantation.
    Yussim A; Efter T; Shmueli D; Shapira Z
    Transplant Proc; 1987 Oct; 19(5):3653-4. PubMed ID: 3313881
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of HLA-specific antibodies in kidney transplant rejection: published studies and local data.
    Worthington JE; Martin S; Barker AJ; McWilliam LJ; Dyer PA
    Clin Transpl; 2006; ():349-61. PubMed ID: 18365389
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Gelatin particle agglutination test for serum antibodies to HIV].
    Yoshida T; Yamamoto N
    Nihon Rinsho; 1988 May; 46(5):1186-93. PubMed ID: 3045370
    [No Abstract]   [Full Text] [Related]  

  • 37. Serum neopterin and beta 2-microglobulin in anti-HIV positive blood donors.
    Lambin P; Desjobert H; Debbia M; Fine JM; Muller JY
    Lancet; 1986 Nov; 2(8517):1216. PubMed ID: 2877345
    [No Abstract]   [Full Text] [Related]  

  • 38. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human immunodeficiency virus antibody screening in patients on renal replacement therapy: prevalence of false-positive results.
    Fassbinder W; Fürsch A; Kühnl P; Schoeppe W
    Nephrol Dial Transplant; 1987; 2(4):248-50. PubMed ID: 3118266
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HIV-2 in perspective.
    Lancet; 1988 May; 1(8593):1027-8. PubMed ID: 2896872
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.